NuVasive had to raise its litigation royalty expense estimate for the year after a U.S. District Court set royalty rates for the company’s CoRoent XL implants at 13.75 percent and MaXcess retractors ...

For some pop stars and composers, the most wonderful time of the year is the summer.

(Reuters) -Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi for COVID-19 vaccines to generate royalties, and reduce selling ...